The Role of Endoscopic Intra-Gastric Botulinum Toxin-A for Obesity Treatment
- 351 Downloads
Obesity prevalence has been increasing with devastating health and economic consequences. Botulinum toxin type A (BTX-A), a neurotoxin, is used clinically for conditions characterized by prolonged muscular contraction. Its inhibitory effects on gastric smooth muscles, in theory, make it a potential agent for obesity treatment through delayed gastric emptying and increased satiety. This review aims to examine the evidence for the use of endoscopic BTX-A injection for treating obesity. The literature search identified 60 articles with 11 primary studies as relevant for the scope of the review. Several studies have been conducted to examine the effect of BTX-A injections on obesity, including both animal and human studies. Current evidence from identified studies does not demonstrate sustained weight loss through the use of endoscopic BTX-A injection.
KeywordsBotulinum toxin-A Endoscopy Obesity
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interested.
Statement of Informed Consent
Statement of Human/Animal Rights
- 2.Stevens GA, Singh GM, Lu Y, et al National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metrics. 2012;10(1).Google Scholar
- 6.Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol. 2016.Google Scholar
- 8.Kendrick ML, Dakin GF. Surgical approaches to obesity. Mayo Clinic Proc. 2006;81(10).Google Scholar
- 9.Colquitt JL, Picot J, Loveman E, et al. Surgery for obesity. Cochrane Database Syst Rev. 2009;(2).Google Scholar
- 15.James AN, Ryan JP, Parkman HP. Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle. Am J Physiol Gastrointest Liver Physiol. 2003; 285(2).Google Scholar
- 26.Foschi D, Corsi F, Lazzaroni M, et al. Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study. Int J Obes. 2007;31(4):707–12.Google Scholar